Share Price and Basic Stock Data
Last Updated: January 7, 2026, 8:27 pm
| PEG Ratio | 0.13 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Chartered Capital & Investment Ltd operates within the Finance & Investments sector, with its share price currently standing at ₹260 and a market capitalization of ₹78.3 Cr. The company reported a significant increase in sales, rising from ₹0.16 Cr in September 2022 to ₹2.19 Cr by September 2023, showcasing a substantial growth trajectory. This upward trend continued into December 2023, with sales reaching ₹2.29 Cr. The trailing twelve months (TTM) sales stood at ₹9.79 Cr, indicating a robust recovery post-pandemic. The annual sales were recorded at ₹2.06 Cr for FY 2023, and projections show an anticipated rise to ₹11.55 Cr by FY 2025. The operating profit margin (OPM) has also improved significantly, moving from negative values in previous quarters to a high of 79.91% in September 2023. This reflects not only operational efficiency but also a growing market demand for its financial services.
Profitability and Efficiency Metrics
Chartered Capital reported a net profit of ₹6.70 Cr, translating to an earnings per share (EPS) of ₹17.88 for FY 2025. The company has demonstrated a commendable improvement in profitability metrics, with the net profit margin reaching 57.57% in March 2025, a stark contrast to the negative margins recorded in prior years. The return on equity (ROE) stood at 3.26%, while the return on capital employed (ROCE) recorded at 4.97% indicates a gradual improvement in capital utilization efficiency. The interest coverage ratio (ICR) is exceptionally high at 438.41x, reflecting the company’s ability to comfortably meet its interest obligations, albeit with no borrowings reported. This financial health is further underscored by an operating profit margin of 62.16%, indicative of strong operational controls and cost management practices.
Balance Sheet Strength and Financial Ratios
The balance sheet of Chartered Capital exhibits significant strength, with total assets reported at ₹174.06 Cr as of March 2025, and total liabilities at ₹174.06 Cr, indicating a well-matched capital structure. The company holds reserves of ₹171.85 Cr, which bolsters its financial stability and provides a cushion against potential market volatilities. Notably, the company has maintained zero borrowings, highlighting its conservative financing strategy and low leverage risk. The price-to-book value (P/BV) ratio is recorded at 0.41x, suggesting that the stock is trading at a discount to its book value, which may indicate an investment opportunity relative to sector norms. The current ratio of 4.39x and quick ratio of 3.96x reflect strong liquidity positions, ensuring that the company can meet short-term liabilities effectively.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Chartered Capital reveals a strong promoter presence, with promoters holding 74.37% of the equity. This entrenched ownership can instill confidence among investors regarding the company’s long-term strategy and governance. The public shareholding stands at 25.63%, with an increasing number of shareholders from 603 in December 2022 to 1,041 by September 2025, reflecting growing interest and confidence in the company’s potential. Despite the absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs), the consistent public participation indicates a positive sentiment towards the stock. The stability in the promoter’s holding percentage further reinforces the trust in the company’s management, which is crucial for maintaining investor confidence and attracting new shareholders.
Outlook, Risks, and Final Insight
Looking ahead, Chartered Capital is poised for continued growth, given its strong sales trajectory and improving profitability metrics. However, potential risks include market volatility that could impact demand for financial services and the company’s ability to maintain its high operating margins. Additionally, the absence of institutional backing could limit liquidity and price stability in the stock. The company’s conservative approach to financing and consistent performance metrics suggest a stable outlook, but vigilance is necessary in a rapidly changing economic landscape. Should the company successfully navigate these challenges, it stands to benefit significantly from its current operational improvements and market positioning, potentially leading to enhanced shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 11.7 Cr. | 40.0 | 61.5/36.4 | 46.9 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,451 Cr. | 307 | 484/280 | 15.8 | 111 | 0.33 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 30.2 Cr. | 0.43 | 1.65/0.38 | 4.19 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 5.04 Cr. | 10.2 | 11.6/8.25 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 20.8 Cr. | 40.5 | 69.9/38.6 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 7,299.15 Cr | 1,354.55 | 76.89 | 3,844.57 | 0.35% | 21.71% | 14.20% | 7.28 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.16 | 0.52 | 0.35 | 0.28 | 2.19 | 2.29 | 1.99 | 1.82 | 2.53 | 2.34 | 2.66 | 2.94 | 1.85 |
| Expenses | 0.35 | 0.39 | 0.42 | 0.34 | 0.44 | 0.52 | 0.43 | 0.71 | 0.64 | 0.93 | 1.21 | 0.72 | 0.70 |
| Operating Profit | -0.19 | 0.13 | -0.07 | -0.06 | 1.75 | 1.77 | 1.56 | 1.11 | 1.89 | 1.41 | 1.45 | 2.22 | 1.15 |
| OPM % | -118.75% | 25.00% | -20.00% | -21.43% | 79.91% | 77.29% | 78.39% | 60.99% | 74.70% | 60.26% | 54.51% | 75.51% | 62.16% |
| Other Income | 0.28 | 0.28 | 0.28 | 0.28 | 0.22 | 0.33 | 0.40 | 0.32 | 0.76 | 0.81 | 0.52 | 0.48 | 0.66 |
| Interest | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.09 | 0.41 | 0.20 | 0.21 | 1.97 | 2.10 | 1.95 | 1.43 | 2.65 | 2.22 | 1.96 | 2.70 | 1.81 |
| Tax % | -11.11% | 17.07% | 40.00% | -4.76% | 25.89% | 21.90% | -9.74% | 28.67% | 49.81% | 24.77% | 29.59% | 25.93% | 8.29% |
| Net Profit | 0.10 | 0.34 | 0.12 | 0.22 | 1.45 | 1.63 | 2.13 | 1.01 | 1.33 | 1.67 | 1.38 | 2.00 | 1.65 |
| EPS in Rs | 0.33 | 1.13 | 0.40 | 0.73 | 4.81 | 5.41 | 7.07 | 3.35 | 4.42 | 5.55 | 4.58 | 6.64 | 5.48 |
Last Updated: December 27, 2025, 2:34 pm
Below is a detailed analysis of the quarterly data for Chartered Capital & Investment Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1.85 Cr.. The value appears to be declining and may need further review. It has decreased from 2.94 Cr. (Jun 2025) to 1.85 Cr., marking a decrease of 1.09 Cr..
- For Expenses, as of Sep 2025, the value is 0.70 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.72 Cr. (Jun 2025) to 0.70 Cr., marking a decrease of 0.02 Cr..
- For Operating Profit, as of Sep 2025, the value is 1.15 Cr.. The value appears to be declining and may need further review. It has decreased from 2.22 Cr. (Jun 2025) to 1.15 Cr., marking a decrease of 1.07 Cr..
- For OPM %, as of Sep 2025, the value is 62.16%. The value appears to be declining and may need further review. It has decreased from 75.51% (Jun 2025) to 62.16%, marking a decrease of 13.35%.
- For Other Income, as of Sep 2025, the value is 0.66 Cr.. The value appears strong and on an upward trend. It has increased from 0.48 Cr. (Jun 2025) to 0.66 Cr., marking an increase of 0.18 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 1.81 Cr.. The value appears to be declining and may need further review. It has decreased from 2.70 Cr. (Jun 2025) to 1.81 Cr., marking a decrease of 0.89 Cr..
- For Tax %, as of Sep 2025, the value is 8.29%. The value appears to be improving (decreasing) as expected. It has decreased from 25.93% (Jun 2025) to 8.29%, marking a decrease of 17.64%.
- For Net Profit, as of Sep 2025, the value is 1.65 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Jun 2025) to 1.65 Cr., marking a decrease of 0.35 Cr..
- For EPS in Rs, as of Sep 2025, the value is 5.48. The value appears to be declining and may need further review. It has decreased from 6.64 (Jun 2025) to 5.48, marking a decrease of 1.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:59 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.26 | 3.14 | 3.27 | 3.88 | 2.35 | 2.06 | 1.32 | 2.16 | 1.66 | 2.06 | 7.92 | 11.55 | 9.79 |
| Expenses | 0.82 | 1.55 | 0.94 | 0.92 | 1.04 | 1.23 | 1.62 | 1.54 | 1.61 | 1.58 | 1.72 | 3.47 | 3.56 |
| Operating Profit | 1.44 | 1.59 | 2.33 | 2.96 | 1.31 | 0.83 | -0.30 | 0.62 | 0.05 | 0.48 | 6.20 | 8.08 | 6.23 |
| OPM % | 63.72% | 50.64% | 71.25% | 76.29% | 55.74% | 40.29% | -22.73% | 28.70% | 3.01% | 23.30% | 78.28% | 69.96% | 63.64% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.04 | 0.21 | 2.47 |
| Interest | 0.28 | 0.28 | 0.29 | 0.23 | 0.04 | 0.06 | 0.12 | 0.09 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 |
| Depreciation | 0.03 | 0.06 | 0.06 | 0.04 | 0.04 | 0.04 | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| Profit before tax | 1.13 | 1.25 | 1.98 | 2.69 | 1.23 | 0.73 | -0.46 | 0.52 | 0.05 | 0.46 | 6.21 | 8.26 | 8.69 |
| Tax % | 14.16% | 43.20% | 20.71% | 12.64% | 13.82% | 20.55% | 6.52% | 15.38% | 160.00% | 28.26% | 12.56% | 34.75% | |
| Net Profit | 0.97 | 0.71 | 1.57 | 2.35 | 1.06 | 0.58 | -0.48 | 0.45 | -0.02 | 0.33 | 5.43 | 5.39 | 6.70 |
| EPS in Rs | 3.22 | 2.36 | 5.21 | 7.80 | 3.52 | 1.93 | -1.59 | 1.49 | -0.07 | 1.10 | 18.03 | 17.90 | 22.25 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -26.80% | 121.13% | 49.68% | -54.89% | -45.28% | -182.76% | 193.75% | -104.44% | 1750.00% | 1545.45% | -0.74% |
| Change in YoY Net Profit Growth (%) | 0.00% | 147.93% | -71.45% | -104.58% | 9.61% | -137.48% | 376.51% | -298.19% | 1854.44% | -204.55% | -1546.19% |
Chartered Capital & Investment Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 54% |
| 3 Years: | 91% |
| TTM: | 26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 68% |
| 3 Years: | 548% |
| TTM: | 3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 35% |
| 3 Years: | 24% |
| 1 Year: | 12% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 2:51 pm
Balance Sheet
Last Updated: December 4, 2025, 2:37 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 |
| Reserves | 18.68 | 19.38 | 20.95 | 53.87 | 52.11 | 41.59 | 29.77 | 49.35 | 76.46 | 121.65 | 159.85 | 164.64 | 171.85 |
| Borrowings | 0.00 | 3.19 | 1.30 | 2.73 | 0.26 | 0.03 | 3.64 | 0.37 | 0.00 | 0.00 | 0.00 | 2.84 | 0.00 |
| Other Liabilities | 0.31 | 0.33 | 0.15 | 0.19 | 0.14 | 0.25 | 0.13 | 0.74 | 2.71 | 7.63 | 2.10 | 3.57 | 4.05 |
| Total Liabilities | 22.00 | 25.91 | 25.41 | 59.80 | 55.52 | 44.88 | 36.55 | 53.47 | 82.18 | 132.29 | 164.96 | 174.06 | 178.91 |
| Fixed Assets | 0.41 | 0.34 | 0.29 | 0.25 | 0.21 | 0.17 | 0.14 | 0.14 | 0.13 | 0.13 | 0.14 | 0.14 | 0.14 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 7.57 | 9.36 | 7.71 | 40.54 | 45.41 | 33.83 | 24.53 | 41.91 | 67.17 | 115.51 | 146.98 | 152.28 | 159.69 |
| Other Assets | 14.02 | 16.21 | 17.41 | 19.01 | 9.90 | 10.88 | 11.88 | 11.42 | 14.88 | 16.65 | 17.84 | 21.64 | 19.08 |
| Total Assets | 22.00 | 25.91 | 25.41 | 59.80 | 55.52 | 44.88 | 36.55 | 53.47 | 82.18 | 132.29 | 164.96 | 174.06 | 178.91 |
Below is a detailed analysis of the balance sheet data for Chartered Capital & Investment Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 3.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.01 Cr..
- For Reserves, as of Sep 2025, the value is 171.85 Cr.. The value appears strong and on an upward trend. It has increased from 164.64 Cr. (Mar 2025) to 171.85 Cr., marking an increase of 7.21 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2.84 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 2.84 Cr..
- For Other Liabilities, as of Sep 2025, the value is 4.05 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.57 Cr. (Mar 2025) to 4.05 Cr., marking an increase of 0.48 Cr..
- For Total Liabilities, as of Sep 2025, the value is 178.91 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 174.06 Cr. (Mar 2025) to 178.91 Cr., marking an increase of 4.85 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.14 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.14 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 159.69 Cr.. The value appears strong and on an upward trend. It has increased from 152.28 Cr. (Mar 2025) to 159.69 Cr., marking an increase of 7.41 Cr..
- For Other Assets, as of Sep 2025, the value is 19.08 Cr.. The value appears to be declining and may need further review. It has decreased from 21.64 Cr. (Mar 2025) to 19.08 Cr., marking a decrease of 2.56 Cr..
- For Total Assets, as of Sep 2025, the value is 178.91 Cr.. The value appears strong and on an upward trend. It has increased from 174.06 Cr. (Mar 2025) to 178.91 Cr., marking an increase of 4.85 Cr..
Notably, the Reserves (171.85 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.44 | -1.60 | 1.03 | 0.23 | 1.05 | 0.80 | -3.94 | 0.25 | 0.05 | 0.48 | 6.20 | 5.24 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 1.62 | 1.16 | 3.35 | 4.70 | 6.21 | 24.81 | 127.20 | 16.90 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 1.62 | 1.16 | 3.35 | 4.70 | 6.21 | 24.81 | 127.20 | 16.90 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Days | 274.56 | -56.96 | 165.20 | 52.68 | 240.74 | 450.05 | -110.61 | 510.32 | 505.72 | 246.29 | 106.46 | 164.96 |
| ROCE % | 6.12% | 6.47% | 8.93% | 6.88% | 2.21% | 1.58% | -0.84% | 1.37% | 0.09% | 0.46% | 4.33% | 4.97% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 17.88 | 18.04 | 1.08 | -0.07 | 1.50 |
| Diluted EPS (Rs.) | 17.88 | 18.04 | 1.08 | -0.07 | 1.50 |
| Cash EPS (Rs.) | 17.93 | 18.07 | 1.11 | -0.04 | 1.53 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 556.68 | 540.79 | 413.95 | 263.89 | 173.88 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 556.68 | 540.79 | 413.95 | 263.89 | 173.88 |
| Revenue From Operations / Share (Rs.) | 31.06 | 22.34 | 3.62 | 2.94 | 4.68 |
| PBDIT / Share (Rs.) | 27.51 | 20.70 | 1.57 | 0.22 | 2.05 |
| PBIT / Share (Rs.) | 27.47 | 20.68 | 1.54 | 0.19 | 2.02 |
| PBT / Share (Rs.) | 27.41 | 20.63 | 1.52 | 0.16 | 1.73 |
| Net Profit / Share (Rs.) | 17.88 | 18.04 | 1.08 | -0.07 | 1.50 |
| PBDIT Margin (%) | 88.58 | 92.66 | 43.26 | 7.73 | 43.79 |
| PBIT Margin (%) | 88.44 | 92.53 | 42.59 | 6.65 | 43.12 |
| PBT Margin (%) | 88.23 | 92.31 | 41.96 | 5.62 | 37.01 |
| Net Profit Margin (%) | 57.57 | 80.74 | 29.95 | -2.44 | 31.95 |
| Return on Networth / Equity (%) | 3.21 | 3.33 | 0.26 | -0.02 | 0.86 |
| Return on Capital Employeed (%) | 4.84 | 3.78 | 0.35 | 0.07 | 1.15 |
| Return On Assets (%) | 3.09 | 3.29 | 0.24 | -0.02 | 0.84 |
| Total Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 |
| Asset Turnover Ratio (%) | 0.05 | 0.04 | 0.01 | 0.01 | 0.03 |
| Current Ratio (X) | 4.39 | 66.12 | 57.24 | 53.58 | 8.44 |
| Quick Ratio (X) | 3.96 | 60.44 | 48.39 | 46.18 | 6.69 |
| Inventory Turnover Ratio (X) | 6.78 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 438.41 | 412.93 | 69.40 | 7.52 | 7.17 |
| Interest Coverage Ratio (Post Tax) (X) | 285.93 | 360.82 | 49.04 | -1.37 | 6.23 |
| Enterprise Value (Cr.) | 64.17 | 58.70 | 33.51 | 23.06 | 13.17 |
| EV / Net Operating Revenue (X) | 6.86 | 8.72 | 30.72 | 26.07 | 9.34 |
| EV / EBITDA (X) | 7.74 | 9.41 | 71.02 | 337.19 | 21.33 |
| MarketCap / Net Operating Revenue (X) | 7.46 | 10.74 | 37.52 | 34.62 | 11.39 |
| Price / BV (X) | 0.41 | 0.44 | 0.32 | 0.38 | 0.30 |
| Price / Net Operating Revenue (X) | 7.46 | 10.74 | 37.53 | 34.63 | 11.39 |
| EarningsYield | 0.07 | 0.07 | 0.01 | 0.00 | 0.02 |
After reviewing the key financial ratios for Chartered Capital & Investment Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 17.88. This value is within the healthy range. It has decreased from 18.04 (Mar 24) to 17.88, marking a decrease of 0.16.
- For Diluted EPS (Rs.), as of Mar 25, the value is 17.88. This value is within the healthy range. It has decreased from 18.04 (Mar 24) to 17.88, marking a decrease of 0.16.
- For Cash EPS (Rs.), as of Mar 25, the value is 17.93. This value is within the healthy range. It has decreased from 18.07 (Mar 24) to 17.93, marking a decrease of 0.14.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 556.68. It has increased from 540.79 (Mar 24) to 556.68, marking an increase of 15.89.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 556.68. It has increased from 540.79 (Mar 24) to 556.68, marking an increase of 15.89.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 31.06. It has increased from 22.34 (Mar 24) to 31.06, marking an increase of 8.72.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 27.51. This value is within the healthy range. It has increased from 20.70 (Mar 24) to 27.51, marking an increase of 6.81.
- For PBIT / Share (Rs.), as of Mar 25, the value is 27.47. This value is within the healthy range. It has increased from 20.68 (Mar 24) to 27.47, marking an increase of 6.79.
- For PBT / Share (Rs.), as of Mar 25, the value is 27.41. This value is within the healthy range. It has increased from 20.63 (Mar 24) to 27.41, marking an increase of 6.78.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 17.88. This value is within the healthy range. It has decreased from 18.04 (Mar 24) to 17.88, marking a decrease of 0.16.
- For PBDIT Margin (%), as of Mar 25, the value is 88.58. This value is within the healthy range. It has decreased from 92.66 (Mar 24) to 88.58, marking a decrease of 4.08.
- For PBIT Margin (%), as of Mar 25, the value is 88.44. This value exceeds the healthy maximum of 20. It has decreased from 92.53 (Mar 24) to 88.44, marking a decrease of 4.09.
- For PBT Margin (%), as of Mar 25, the value is 88.23. This value is within the healthy range. It has decreased from 92.31 (Mar 24) to 88.23, marking a decrease of 4.08.
- For Net Profit Margin (%), as of Mar 25, the value is 57.57. This value exceeds the healthy maximum of 10. It has decreased from 80.74 (Mar 24) to 57.57, marking a decrease of 23.17.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.21. This value is below the healthy minimum of 15. It has decreased from 3.33 (Mar 24) to 3.21, marking a decrease of 0.12.
- For Return on Capital Employeed (%), as of Mar 25, the value is 4.84. This value is below the healthy minimum of 10. It has increased from 3.78 (Mar 24) to 4.84, marking an increase of 1.06.
- For Return On Assets (%), as of Mar 25, the value is 3.09. This value is below the healthy minimum of 5. It has decreased from 3.29 (Mar 24) to 3.09, marking a decrease of 0.20.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.05. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 4.39. This value exceeds the healthy maximum of 3. It has decreased from 66.12 (Mar 24) to 4.39, marking a decrease of 61.73.
- For Quick Ratio (X), as of Mar 25, the value is 3.96. This value exceeds the healthy maximum of 2. It has decreased from 60.44 (Mar 24) to 3.96, marking a decrease of 56.48.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.78. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 6.78, marking an increase of 6.78.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 438.41. This value is within the healthy range. It has increased from 412.93 (Mar 24) to 438.41, marking an increase of 25.48.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 285.93. This value is within the healthy range. It has decreased from 360.82 (Mar 24) to 285.93, marking a decrease of 74.89.
- For Enterprise Value (Cr.), as of Mar 25, the value is 64.17. It has increased from 58.70 (Mar 24) to 64.17, marking an increase of 5.47.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.86. This value exceeds the healthy maximum of 3. It has decreased from 8.72 (Mar 24) to 6.86, marking a decrease of 1.86.
- For EV / EBITDA (X), as of Mar 25, the value is 7.74. This value is within the healthy range. It has decreased from 9.41 (Mar 24) to 7.74, marking a decrease of 1.67.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.46. This value exceeds the healthy maximum of 3. It has decreased from 10.74 (Mar 24) to 7.46, marking a decrease of 3.28.
- For Price / BV (X), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 1. It has decreased from 0.44 (Mar 24) to 0.41, marking a decrease of 0.03.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.46. This value exceeds the healthy maximum of 3. It has decreased from 10.74 (Mar 24) to 7.46, marking a decrease of 3.28.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Chartered Capital & Investment Ltd:
- Net Profit Margin: 57.57%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.84% (Industry Average ROCE: 21.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.21% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 285.93
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.96
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11.7 (Industry average Stock P/E: 76.89)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 57.57%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | 711, Mahakant, Opp. V S Hospital, Ahmedabad Gujarat 380006 | info@charteredcapital.net http://www.charteredcapital.net |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mohib N Khericha | Managing Director |
| Mrs. Sofia M Khericha | Non Executive Director |
| Mr. Nawalkishor D Gupta | Independent Director |
| Mr. Zohar E Rangwala | Independent Director |
FAQ
What is the intrinsic value of Chartered Capital & Investment Ltd?
Chartered Capital & Investment Ltd's intrinsic value (as of 08 January 2026) is ₹180.83 which is 30.72% lower the current market price of ₹261.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹78.6 Cr. market cap, FY2025-2026 high/low of ₹439/200, reserves of ₹171.85 Cr, and liabilities of ₹178.91 Cr.
What is the Market Cap of Chartered Capital & Investment Ltd?
The Market Cap of Chartered Capital & Investment Ltd is 78.6 Cr..
What is the current Stock Price of Chartered Capital & Investment Ltd as on 08 January 2026?
The current stock price of Chartered Capital & Investment Ltd as on 08 January 2026 is ₹261.
What is the High / Low of Chartered Capital & Investment Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Chartered Capital & Investment Ltd stocks is ₹439/200.
What is the Stock P/E of Chartered Capital & Investment Ltd?
The Stock P/E of Chartered Capital & Investment Ltd is 11.7.
What is the Book Value of Chartered Capital & Investment Ltd?
The Book Value of Chartered Capital & Investment Ltd is 581.
What is the Dividend Yield of Chartered Capital & Investment Ltd?
The Dividend Yield of Chartered Capital & Investment Ltd is 0.00 %.
What is the ROCE of Chartered Capital & Investment Ltd?
The ROCE of Chartered Capital & Investment Ltd is 4.97 %.
What is the ROE of Chartered Capital & Investment Ltd?
The ROE of Chartered Capital & Investment Ltd is 3.26 %.
What is the Face Value of Chartered Capital & Investment Ltd?
The Face Value of Chartered Capital & Investment Ltd is 10.0.